×
返回 Agenda
S27 : Clinical Trials 2035: Innovations That will Transform the Future of Research
Session Chair(s)
Shigeru Nakaji, MSC
Vice President, RD Opearations, CRDO Office, Astellas Pharma Inc., Japan
Speaker(s)
Janice Chang
Chief Executive Officer , TransCelerate Biopharma Inc., United States
Mamoru Narukawa, PHD, RPH
Professor, Kitasato University, Japan
Takuko Sawada
Director and Vice Chairperson of the Board, Shionogi & Co., Ltd., Japan
Christoph Koenen, MD, MBA
Global Head of Clinical Development and Operations, Bayer Ag, Swaziland
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan